Endeavour Vision
Geneva-based venture capital and growth equity firm investing in growth-stage medical technology, diagnostics and digital health companies, partnering on commercial development.
Endeavour Vision is a Geneva-headquartered venture capital and growth equity firm investing in growth-stage, commercially ready companies across medical devices, diagnostics, digital health and healthcare technology. Its mandate is to back businesses addressing significant unmet health needs, with an emphasis on technologies intended to improve patient outcomes and streamline healthcare delivery. The firm considers opportunities in Europe and North America as well as beyond those regions.
Investment activity concentrates on the growth stage - that is, companies with products on or near the market and a commercial case to develop - rather than on early-stage formation capital. Support extends past the transaction: the firm works with portfolio companies on commercial strategy, clinical trials, regulatory submissions, environmental policy and asset acquisitions, and makes introductions through a network spanning healthcare and finance. Environmental, social and governance (ESG) factors are considered throughout the investment cycle, and the firm advises portfolio companies on strengthening their sustainability practices. The stated objective is to generate social as well as financial returns.
The team combines healthcare technology and therapeutic-area expertise with knowledge of financial markets, and is composed of entrepreneurs, scientists and investment professionals. Industry focus spans healthcare, medical devices, diagnostics, digital health and life sciences.